Short-term therapies for treatment of acute and advanced heart failure—why so few drugs available in clinical use, why even fewer in the pipeline?

Piero Pollesello*, Tuvia Ben Gal, Dominique Bettex, Vladimir Cerny, Josep Comin-Colet, Alexandr A. Eremenko, Dimitrios Farmakis, Francesco Fedele, Cândida Fonseca, Veli Pekka Harjola, Antoine Herpain, Matthias Heringlake, Leo Heunks, Trygve Husebye, Visnja Ivancan, Kristian Karason, Sundeep Kaul, Jacek Kubica, Alexandre Mebazaa, Henning MølgaardJohn Parissis, Alexander Parkhomenko, Pentti Põder, Gerhard Pölzl, Bojan Vrtovec, Mehmet B. Yilmaz, Zoltan Papp

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Short-term therapies for treatment of acute and advanced heart failure—why so few drugs available in clinical use, why even fewer in the pipeline?'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science